Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 20 Jul 2026 for AKTIS ONCOLOGY, INC., €104k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Ken Herrmann: trading record in brief
This profile gathers the share dealings of Ken Herrmann in Aktis Oncology, Inc. Over a trading history stretching from 17 July 2026 to 20 July 2026, the count stands at 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 20 July 2026 came the latest disclosure, a transaction for €104k in Aktis Oncology, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Ken Herrmann
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
4,856 shares@ US$24.5623CommonSEC144:0001950047-26-007234
3,065 shares@ US$25.20670.0056% mcap100.0% of flowCommonSEC144:0001950047-26-007199
2 of 2 declarations
